Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas.

Guo, Zhanjun; Li, Heng-Hong; Shiao, Yih-Horng

Guo, Zhanjun; Li, Heng-Hong; Shiao, Yih-Horng.

Guo Z; Department of Immunology and Rheumatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Li HH; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States.
Shiao YH; United Department of Commerce, States Patent and Trademark Office, Alexandria, VA, United States.

Front Oncol ; 12: 860964, 2022.

Article in English | MEDLINE | ID: covidwho-1792990

Keywords

Hepatocellular carcinomas; PD-1; PD-L1; bioinformatics; biomarkers; immune-checkpoint inhibitors; immunotherapies

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Front Oncol Year: 2022 Document Type: Article Affiliation country: Fonc.2022.860964

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google